Reata Pharma

Small molecules for melanoma, pulmonary hypertension, friedreich’s ataxia, mitochondrial myopathies and cataract surgery patients

placeIrving, Texas, United States calendar_todayFounded 2002 groups363 employees language reatapharma.com

Registered entities

Investor mix

11 investors on record; lead investors include Novo Holdings; 4 have since exited.

Investor typeCountShare
Venture capital218%
Private equity545%
Bank & private debt19%
Other / undisclosed327%
Coming soon